Sulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response

Toxicology and Applied Pharmacology

Volumn 247, Issue 2, 2010, Pages 129-137

  Gan, Nanqin ^a   Mi, Lixin ^b   Sun, Xiaoyun ^a   Dai, Guofei ^a   Chung, Fung Lung ^b   Song, Lirong ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Chemoprevention; Glutathione (GSH); Microcystin LR (MC LR); NF E2 related factor 2 (Nrf2); Phase II enzymes; Sulforaphane (SFN)

Indexed keywords

GLUTATHIONE; HEME OXYGENASE 1; MICROCYSTIN LR; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASSAY; CELL DAMAGE; CELL LEVEL; CELL LINE; CELL PROTECTION; CELL SELECTION; CELL STRAIN HEPG2; CELL VIABILITY; CHEMICAL STRUCTURE; COLONY FORMATION; CYTOTOXICITY; GENE; HUMAN; HUMAN CELL; INTROSPECTION; MOUSE; NONHUMAN; RAT; TRANSACTIVATION; WATER CONTAMINATION;

MICROCYSTIS;

EID: 77955266905     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.06.005     Document Type: Article

References (38)

1. Brook J.D., Paton V.G., Vidanes G. Potent induction of phase 2 enzymes in human prostate cells by Sulforaphane. Cancer Epidemiol. Biomark. Prev. 2001, 10:949-954.
2. Carmichael W.W. The toxins of cyanobacteria. Sci. Am. 1994, 270:78-86.
3. Cho H.Y., Jedlicka A.E., Reddy S.P., Kensler T.W., Yamamoto M., Zhang L.Y., Kleeberger S.R. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 2002, 26:175-182.
4. Cornblatt B.S., Ye L.X., Dinkova-Kostova A.T., Erb M. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 2007, 28:1485-1490.
5. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11908-11913.
6. Du Y., Villeneuve N.F., Wang X.J., Sun Z.H., Chen W.M., Li J.X., et al. Oridonin Confers Protection against Arsenic-Induced Toxicity through Activation of the Nrf2-Mediated Defensive Response. Environ. Health Perspect. 2008, 116:1154-1161.
7. Falconer I.R. Toxic cyanobacterial bloom problems in Australian waters: risks and impacts on human health. Phycologia 2001, 40:228-233.
8. Fowke J.H., Chung F.L., Jin F., Qi D., Cai Q., et al. Urinary isothiocyanate levels, brassica, and human breast cancer. Cancer Res. 2003, 63:3980-3986.
9. Gao X., Dinkova-Kostova A.T., Talalay P. Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:15221-15226.
10. Gehringer M.M., Govender S., Shah M. An investigation of the role of vitamin E in the protection of mice against microcystin toxicity. Environ. Toxicol. 2003, 18:142-148.
11. Gehringer M.M., Shephard E.G., Downing T.G., Wiegand C., Neilan B.A. An investigation into the detoxification of microcystin-LR by the glutathione pathway in Balb/c mice. Int. J. Biochem. Cell Biol. 2004, 36:931-941.
12. Hayes J.D., Chanas S.A., Henderson C.J., McMahon M., Sun C., Moffat G.J., et al. The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin. Biochem. Soc. Trans. 2000, 28:33-41.
13. Jeong W.S., Jun M., Kong A.N. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid. Redox Signal. 2006, 8:99-106.
14. Jochimsen E.M., Carmichael W.W., Jisi A. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. New Engl. J Med. 1998, 338:873-878.
15. Joseph M.A., Moysich K.B., Freudenheim J.L., Shields P.G., Bowman E.D., et al. Cruciferous vegetables, genetic polymorphisms in glutathione S-transferases M1 and T1, and prostate cancer risk. Nutr. Cancer 2004, 50:206-213.
16. Kensler T.W., Wakabayashi N., Biswal S. Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
17. Kim B.R., Hu R., Keum Y.S., Hebbar V., Shen G., Nair S.S., Kong A.N. Effects of glutathione on antioxidant response element-mediated gene expression and apoptosis elicited by sulforaphane. Cancer Res. 2003, 63:7520-7525.
18. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24:7130-7139.
19. Kong A.N., Yu R., Hebbar V., Chen C., Owuor E., Hu R., et al. Signal transduction events elicited by cancer prevention compounds. Mutat. Res. 2001, 480-481:231-241.
20. Lin H.J., Probst-Hensch N.M., Louie A.D., Kau I.H., Witte J.S., et al. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomark. Prev. 1998, 7:647-652.
21. Moffit J.S., Aleksunes L.M., Kardas M.J., Slitt A.L., Klaassen C.D., Manautou J.E. Role of NAD(P)H:quinone oxidoreductase 1 in clofibrate-mediated hepatoprotection from acetaminophen. Toxicology 2007, 230:197-206.
22. Pflugmacher S., Wiegand C., Oberemm A., Beattie K.A., Krause E., Codd G.A., et al. Identification of an enzymatically formed glutathione conjugate of the cyanobacterial hepatotoxin microcystin LR: the first step in detoxification. Biochim. Biophys. Acta 1998, 1425:527-533.
23. Prestera T., Talalay P. Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:8965-8969.
24. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J. Clin. Invest. 2004, 114:1248-1259.
25. Reisman S.A., Aleksunes L.M., Klaassen C.D. Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Biochem. Pharmacol. 2009, 77:1273-1282.
26. Riley R.J., Workman P. DT-diaphorase and cancer chemotherapy. Biochem. Pharmacol. 1992, 43:1657-1669.
27. Shinkai Y., Sumi D., Fukami I., Ishii T., Kumagai Y. Sulforaphane, an activator of Nrf2, suppresses cellular accumulation of arsenic and its cytotoxicity in primary mouse hepatocytes. FEBS Lett. 2006, 580:1771-1774.
28. Spitz M.R., Duphorne C.M., Detry M.A., Pillow P.C., Amos C.I., et al. Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk. Cancer Epidemiol. Biomark. Prev. 2000, 9:1017-1020.
29. Sutherland B.M., Bennett P.V., Freeman A.G., Moore S.P., Strickland P.T. Transformation of human cells by DNAs ineffective in transformation of NIH 3T3 cells. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:2399-2403.
30. Takenaka S. Covalent glutathione conjugation to cyanobacterial hepatotoxin microcystin LR by F344 rat cytosolic and microsomal glutathione S-transferases. Environ. Toxicol. Pharmacol. 2001, 9:135-139.
31. Ueno Y., Nagata S., Tsutsumi T., Yu S.Z. Detection of microcystins, a blue-green algal hepatotoxin, in drinking water sample in Haimen and Fusui, endemic areas of Primary Liver Cancer in China, by highly sensitive immunoassay. Carcinogenesis 1996, 17:1317-1321.
32. WHO Guidelines for drinking-water quality. Addendum to Volume 2. Health Criteria and Other Supporting Information 1998, Word Health Organization, Genveva, Switzerland.
33. William O.O., Thomas W.K. Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults. Mutat. Res./Rev. Mutat. Res. 2008, 659:31-39.
34. Yates M.S., Tran Q.T., Dolan P.M., Osburn W.O., Shin S., et al. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 2009, 30:1024-1031.
35. Yoon H.Y., Kang N.I., Lee H.K., Jang K.Y., Park J.W., Park B.H. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem. Pharmacol. 2008, 75:2214-2223.
36. Zegura B., Lah T.T., Filipic M. Alteration of intracellular GSH levels and its role in microcystin- LR-induced DNA damage in human hepatoma HepG2 cells. Mutat. Res. 2006, 611:25-33.
37. Zhang D.D., Lo S.C., Sun Z.H., Habib G.M., Lieberman M.W., Hannink M. Ubiquitination of Keap1, a BTB-Kelch Substrate Adaptor Protein for Cul3, Targets Keap1 for Degradation by a Proteasome-independent Pathway. J. Biol. Chem. 2005, 280:30091-30099.
38. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 2006, 38:769-789.